Fernand Labrie
Publications
Page 1 of 8, showing 50 records out of 360 total, starting on record 1, ending on 50
| Publication | Category | Year |
|---|---|---|
|
360. Akaza, H., Labrie, F., Namiki, M. (2007) [A way of thinking of a MAB therapy for local/locally advanced prostate cancer: the theory and recent evaluation]. Gan To Kagaku Ryoho. Jpn J Cancer Chemotherapy, 34: 657-669. Attached files: AkazaH(2007)Article Japonais-Jpn J Cancer Chemother.pdf |
Prostate Cancer | 2007 |
|
359. Boivin, R.P., Poirier, D., Labrie, F. (1999) 17alpha-alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity. Steroids, 64: 825-833. Attached files: BoivinRP(1999)17-alpha-alkan (or alkyn)....pdf |
Prostate Cancer | 1999 |
|
358. Candas, B., Cusan, L., Gomez, J.-L., Diamond, P., Suburu, R.E., Lévesque, J., Brousseau, G., Bélanger, A., Labrie, F. (2000) Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Prostate, 45: 19-35. Attached files: CandasB(2000)Evaluation of prostatic andtigen.....pdf |
Prostate Cancer | 2000 |
|
357. Candas, B., Labrie, F., Gomez, J.L., Cusan, L., Chevrette, E., Levesque, J., Brousseau, G. (2006) Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits. J Urol, 175: 510-517. Attached files: CandasB(2006)Relationship among initial serum....pdf |
Prostate Cancer | 2006 |
|
356. Cantin, L., Faucher, F., Couture, J.F., de Jésus, K.P., Legrand, P., Ciobanu, L., Fréchette, Y., Labrecque, R., Singh, S.M., Labrie, F., Breton, R. (2007) Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally-designed steroidal ligand bearing a bulky chain directed toward helix 12. J Biol Chem, 282: 30910-9. Attached files: CantinL(2007)Structural characterization of.....pdf |
Prostate Cancer | 2007 |
|
355. Crawford, E.D., Miller, G., Labrie, F., Hirano, D., Batuello, J., Globe, M. (2001) Prostate cancer pathology, screening and epidemiology. Reviews in Urology, 3: S2-S10. Attached files: CrawfordED(2001)Prostate cancer pathology......pdf |
Prostate Cancer | 2001 |
|
354. El-Alfy, M., Luu-The, V., Huang, X.F., Berger, L., Labrie, F., Pelletier, G. (1999) Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology, 140: 1481-1491. Attached files: El-AlfyM(1999)Localization of type 5,17....pdf |
Prostate Cancer | 1999 |
|
353. El-Alfy, M., Pelletier, G. Hermo, L.S., Labrie, F. (2000) Unique features of the basal cells of human prostate epithelium. Microsc. Res. Tech., 51: 436-446. Attached files: El-AlfyM(2000)Unique features of the basal cells.....pdf |
Prostate Cancer | 2000 |
|
352. Gomella, L.G., Labrie, F., Gamito, E.J., Brawer, M.K. (2001) Prostate cancer: risk assessment and diagnostic approaches. Reviews in Urology, 3: S31-S38. Attached files: GomellaLG(2001)Prostate cancer Risk assessment and......pdf |
Prostate Cancer | 2001 |
|
351. Kelloff, G.J., Lieberman, R., Brawer, M.K., Crawford, E.D., Labrie, F., Miller, G.J. (1999) Strategies for chemoprevention of prostate cancer. Prostate Cancer and Prostatic Diseases, 2: 27-33. Attached files: KelloffGJ(1999)Strategies for chemoprevention....pdf |
Prostate Cancer | 1999 |
|
350. Lévesque, M.H., El-Alfy, M., Cusan, L., Labrie, F. (2009) Androgen receptor as a potential sign of prostate cancer metastasis, The Prostate, 69: 1704-1711. Attached files: LevesqueMH(2009)Androgen receptor.....pdf |
Prostate Cancer | 2009 |
|
349. Labrie, C., Flamand, M., Bélanger, A., Labrie, F. (1996) High bioavailability of DHEA administered percutaneously in the rat. J. Endocrinol., 150: S107-S118. Attached files: LabrieC(1996)High bioavailabiltiy of dehydro....pdf |
Prostate Cancer | 1996 |
|
348. Labrie, F. (2000) Prostate cancer and combined androgen blockade at all stages of disease, in: Khayat, D. et Hortobagyi, G.N., eds: Progress in Anti-Cancer Chemotherapy, France, Springer, pp 171-187. Attached files: LabrieF(2000)Prostate cancer and combined androgen.....pdf |
Prostate Cancer | 2000 |
|
347. Labrie, F. (2000) Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support. Prostate, 43: 214-222. Attached files: LabrieF(2000)Screening and early hormonal treatment......pdf |
Prostate Cancer | 2000 |
|
346. Labrie, F. (2000) Screening and hormonal therapy of localized prostate cancer show major benefits on survival. Cancer J. Sci. Am., 6: S182-S187. Attached files: LabrieF(2000)Screening and hormonal therapy of ......pdf |
Prostate Cancer | 2000 |
|
345. Labrie, F. (2001) Le cancer de la prostate: blocage combiné des androgènes comme traitement à tous les stades de la maladie. Oncologie, 3: 3-12. Attached files: LabrieF(2001)Le cancer de la prostate blocage combine.....pdf |
Prostate Cancer | 2001 |
|
344. Labrie, F. (2002) Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease. Mol Cell Endocrinol, 198: 77-87. Attached files: LabrieF(2002)Androgen blockade in prostate.....pdf |
Prostate Cancer | 2002 |
|
343. Labrie, F. (2002) Endocrine-sensitive cancers of the prostate and breast, in: Baster, J., Melmed, S. et New, M., eds: Genetics in Endocrinology, Lippincott-William and Wilkins, pp 607-661. Attached files: LabrieF(2002)Endocrine-Sensitive cancer of the .....pdf |
Prostate Cancer | 2002 |
|
342. Labrie, F. (2003) Hormonal therapy in the management of prostate cancer at all stages of the disease, in: Syrigos, K.N., ed. Prostate Cancer: Biology, Diagnosis and Management, London, UK, Oxford University Press, pp 301-314. Attached files: LabrieF(2003)Hormonal therapy in the management of prostate cancer.....pdf |
Prostate Cancer | 2003 |
|
341. Labrie, F. (2004) Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility. Brazilian J Urol, 30: 3-12. Attached files: LabrieF(2004)Current status of endocrine therapy.....pdf |
Prostate Cancer | 2004 |
|
340. Labrie, F. (2004) Major role of androgen blockade in the success of prostate cancer treatment: cure has become a very good possibility. Prostate Cancer Communication Newsletter, 20: 3-11. Attached files: LabrieF(2004)Major role of androgen blockade in the success.....pdf |
Prostate Cancer | 2004 |
|
339. Labrie, F. (2004) Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. J Androl, 25: 305-313. Attached files: LabrieF(2004)Medical castration wiht LHRH agonists.....pdf |
Prostate Cancer | 2004 |
|
338. Labrie, F. (2004) Status of androgen blockade in prostate cancer in 2003, in: Koutsilieris, M. et Labrie, F., eds: Prostate cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 157-170. Attached files: LabrieF(2004)Status of androgen blockade in prostate cancer.....pdf |
Prostate Cancer | 2004 |
|
337. Labrie, F. (2006) Keyrole of endocrinology in the victory against prostate cancer. Bull. Cancer, 93: 949-58. Attached files: LabrieF(2006)Role cle de l'endo...Bull Cancer.pdf |
Prostate Cancer | 2006 |
|
336. Labrie, F. (2007) Multiple intracrine hormonal targets in the prostate: oportunities and challenges. BJU Int, 100: 48-51. Attached files: LabrieF(2007)Multiple intracrine hormonal....pdf |
Prostate Cancer | 2007 |
|
335. Labrie, F. (2008) Comment to: Prostate specific antigen (PSA)-based screening. Int J Urol, 15: 757-762. Attached files: LabrieF(2008)Comment to Prostate specific antigen....pdf |
Prostate Cancer | 2008 |
|
334. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J., Candas, B. (2005) Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine Reviews, 26: 361-379. Attached files: LabrieF(2005)Gonadotropin-releasing..pdf |
Prostate Cancer | 2005 |
|
333. Labrie, F., Bélanger, A., Simard, J., Luu-The, V., Labrie, C., Lin, S.-X., Candas, B., Cusan, L. (1999) Impact de l'intracrinologie dans la thérapeutique et la prévention des cancers du sein et de la prostate et de la ménopause, in: Guérité, N. et Leclère, J., eds: Mises au point cliniques d'endocrinologie, nutrition et métabolisme 1999, Paris, France, Les Éditions de Médecine Pratique, pp 169-204. Attached files: LabrieF(1999)Impact de l'intracrinologie dans la .....pdf |
Prostate Cancer | 1999 |
|
332. Labrie, F., Candas, B. (1999) Bicalutamide versus Flutamide in combination therapy [Letter to the Editor re: Schellhammer et al. 50: 330-336, 1997]. Urology, 53: 662-663. Attached files: LabrieF(1999)Bicalutamide versus flutamide in.....pdf |
Prostate Cancer | 1999 |
|
331. Labrie, F., Candas, B. (1999) The Quebec study shows a 69% decrease in prostate cancer death [Authors' Response to comment of Alexander and Prescott on Prostate 38 (2): 83-91, 1999]. Prostate, 40: 137. Attached files: LabrieF(1999)The Quebec study shows a .....pdf |
Prostate Cancer | 1999 |
|
330. Labrie, F., Candas, B. (1999) Various statistical analyses indicate a marked reduction of prostate cancer death in the Quebec trial [Authors' Response to comment of Boer and Schroder on Prostate 38 (2): 83-91, 1999]. Prostate, 40: 132-134. Attached files: LabrieF(1999)Various satistical analysis .....pdf |
Prostate Cancer | 1999 |
|
329. Labrie, F., Candas, B. (2000) Androgen blockade in prostate cancer [Letter-to-the-Editor]. Lancet, 356: 341-342. Attached files: LabrieF(2000)Androgen blockade in prostate cancer.....pdf |
Prostate Cancer | 2000 |
|
328. Labrie, F., Candas, B., Cusan, L., Gomez, J.L. (2001) The Laval University screening trial results (Chapter 17), in: Thompson, I.M., Resnick, M.I. et Klein, E.A., eds: Current Clinical Urology, Prostate Cancer Screening, Totowa, NJ, Humana Press Inc., pp 255-279. Attached files: LabrieF(2001)The Laval University screening trial......pdf |
Prostate Cancer | 2001 |
|
327. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Bélanger, A., Brousseau, G., Lévesque, J. (2004) Screening decreases prostate cancer mortality: 11-year follow-up on the 1988 Quebec prospective randomized controlled trial. The Prostate, 59: 311-318. Attached files: LabrieF(2004)Screening decreases prostate.....pdf |
Prostate Cancer | 2004 |
|
326. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M. (1996) Diagnosis of advanced or non-curable prostate cancer can be practically eliminated by prostate-specific antigen. Urology, 47: 212-217. Attached files: LabrieF(1996)Diagnosis of advanced or noncurable.....pdf |
Prostate Cancer | 1996 |
|
325. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Lévesque, J., Chevrette, E., Brousseau, G. (2004) Prostate Cancer Screening and Early Treatment: The Only Possibility for a Major Impact on Survival in Prostate Cancer, in: Labrie, F. et Koutsilieris, M., eds: Prostate Cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 67-78. Attached files: LabrieF(2004)Prostate Cancer screening and early.....pdf |
Prostate Cancer | 2004 |
|
324. Labrie, F., Candas, B., Dupont, A., Cusan, L., Gomez, J.L., Suburu, R.E., Diamond, P., Lévesque, J., Bélanger, A. (1999) Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate, 38: 83-91. Attached files: LabrieF(1999(Screening decreases prostate.....pdf |
Prostate Cancer | 1999 |
|
323. Labrie, F., Candas, B., Gomez, L.J., Cusan, L. (2002) Can combined androgen blockade provide long term control or possible cure of localized prostate cancer? Urology, 60: 115-119. Attached files: LabrieF(2002)Can combined androgen blockade.....pdf |
Prostate Cancer | 2002 |
|
322. Labrie, F., Cusan, J., Gomez, J., Levesque, J., Candas, B. (1999) Screening and treatment of localized prostate cancer decreases mortality: first analysis of the first prospective and randomized study on prostate cancer screening. Society of the Study of the Aging Male, 2: 33-43. Attached files: LabrieF(1999)Screening and treatment of......pdf |
Prostate Cancer | 1999 |
|
321. Labrie, F., Cusan, L., Gomez, J., Luu-The, V., Candas, B., Bélanger, A., Labrie, C. (2004) Major impact of hormonal therapy in localized prostate cancer - death can already be an exception. JSBMB, 92: 327-344. Attached files: LabrieF(2004)Major impact of hormonal therapy in....pdf |
Prostate Cancer | 2004 |
|
320. Labrie, F., Cusan, L., Gomez, J.L., Candas, B., Bélanger, A., Luu-The, V., Simard, J. (2003) De la biologie à la clinique: le décès dû au cancer de la prostate peut-il maintenant être une exception? Médecine/Sciences, 19: 910-19. Attached files: LabrieF(2003)De la biologie a la clinique.....pdf |
Prostate Cancer | 2003 |
|
319. Labrie, F., Cusan, L., Gomez, J.L., Martel, C., Bérubé, R., Bélanger, P., Bélanger, A., Vandenput, L., Mellström, D., Ohlsson, C. (2009) Comparable Amounts of Sex Steroids are Made Outside the Gonads in Men and Women: Strong Lesson for Hormone Therapy of Prostate and Breast Cancer, JSBMB, 113: 52-56. Attached files: LabrieF(2009)Comparable amounts of sex.....pdf |
Prostate Cancer | 2009 |
|
318. Labrie, F., Koutsilieris, M. (2008) The 12th International Congress on Hormonal Steroids and Hormones & Cancer. J Steroid Biochem Mol Biol, 108: 179. Attached files: LabrieF(2008)KoutsilierisM-PrefaceJSBMB 108 p179.pdf |
Prostate Cancer | 2008 |
|
317. Labrie, F., Luu-The, V., Bélanger, A., Lin, S.-X., Simard, J., Pelletier, G., Labrie, C. (2005) Is DHEA a hormone? Starling Review. J Endocrinol, 187: 169-196. Attached files: LabrieF(2005)Is DHEA a hormone....pdf |
Prostate Cancer | 2005 |
|
316. Labrie, F., Luu-The, V., Labrie, C., Simard, J. (2001) DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Neuroendocrinologie, 22: 185-212. Attached files: LabrieF(2001)DHEA and its transformation into ........pdf |
Prostate Cancer | 2001 |
|
315. Labrie, F., Luu-The, V., Lin, S.-X., Simard, J., Labrie, C. (2000) Role of 17β-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol. Metab., 11: 421-427. Attached files: LabrieF(2000)Role of 17b-hydroxysteroid dehydrogenases.....pdf |
Prostate Cancer | 2000 |
|
314. Labrie, F., Luu-The, V., Lin, S.-X., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., Bélanger, A. (2000) Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J. Mol. Endocrinol., 25: 1-16. Attached files: LabrieF(2000)Intracrinology Role of the family of ......pdf |
Prostate Cancer | 2000 |
|
313. Labrie, F., Simard, J., Candas, B. (1997) Reply by the authors to: Editorial comment of: Comparison of in vitro effects of the pure antiandrogens OH-Flutamide, Casodex and Nilutamide on androgen-sensitive parameters [Reply to the authors/P.F. Schellhammer]. Urology, 49: 586-589. Attached files: LabrieF(1997)Urology 49-586-589.pdf |
Prostate Cancer | 1997 |
|
312. Labrie, F., Simard, J., Singh, S.M., Candas, B. (1997) Estimated potency of Casodex: A problematic design [Letter to the Editor re Schellhammer et al. 45: 745-52, 1995]. Urology, 50: 309-313. Attached files: LabrieF(1997)Urology 50-309-313.pdf |
Prostate Cancer | 1997 |
|
311. Levesque, M.H., El-Alfy, M., Berger, L., Labrie, F., Labrie, C. (2007) Evaluation of AIbZIP and Cdc47 as Markers for Human Prostatic Diseases. Urology, 69: 196-201. Attached files: LevesqueMH(2007)Evaluation of albZIP and....pdf |
Prostate Cancer | 2007 |